US EditionValneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
7 Articles
7 Articles
According to the latest report from Public Health France, 26 cases of chikungunya have already been recorded in the Hexagon. Such precocity worries the experts, who fear a risk of epidemic similar to the territories of the Indian Ocean, like Mayotte or La Réunion. Interview with Anna-Bella Failloux, entomologist and professor at the Institut Pasteur.
Valneva Announces Lifting of European Medicines Agencys Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ in Elderly
Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ® by EMA’s safety committee (PRAC). […] The post Valneva Announces Lifting of European Medicines Agencys T…
Medscape
Anti-Aging, Acupuncture and Health NewsEMA Lifts Chikungunya Vaccine Restriction – With Care
The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only when there is significant risk of infection. Medscape Medical News
In the Alsace region of France, doctors diagnosed a patient with chikungunya fever. This is a tropical viral disease. The problem is that the man didn't catch it while traveling—he contracted the alphavirus in Europe. Are we facing an epidemic?
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium
